Clinical Trial Update: Sphenopalatine Ganglion Block for Post-Dural Puncture Headache in Orthopedic Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating sphenopalatine ganglion block for post-dural puncture headache in orthopedic patients; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-dural Puncture Headache

Drugs mentioned

• Adrenaline (epinephrine)
• Sphenopalatine ganglion block

Snippet

Sponsor: Tanta University | Conditions: Sphenopalatine Ganglion Block, Adrenaline | Phase 4 | Status: UNKNOWN